Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LINCOLN | NSE
29.90
5.29%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
594.85
575.00
603.00
569.10
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold anti-allergic and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins minerals and antioxidants; anti-bacterial anti-viral and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic anti-convulsant anti-depressant and anti-diabetic; cardiac anti-hypertensives and diuretic; and anti-diarrheal anti-spasmodic and laxative as well as dermatologist preparations gynecological products gastrointestinal rang otology products and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics. The company was incorporated in 1979 and is based in Ahmedabad India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
40.4%1 month
33.9%3 months
52.0%6 months
39.4%13.55
-
2.23
0.00
0.00
8.75
2.05
-
1.02B
11.91B
127.86M
0.27
13.25
24.60
8.60
17.04
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
57.10
Range1M
91.05
Range3M
237.00
Rel. volume
0.48
Price X volume
9.84M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 1365.6 | 11.62B | 8.46% | 104.15 | 83.75% |
| Venus Remedies Limited | VENUSREM | Drug Manufacturers-Specialty & Generic | 861.05 | 11.51B | 5.00% | 16.58 | 8.48% |
| Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 311.7 | 9.79B | 7.45% | n/a | 119.57% |
| SAKAR | SAKAR | Drug Manufacturers-Specialty & Generic | 515.65 | 8.69B | 3.45% | 59.39 | 30.25% |
| Ind-Swift Laboratories Limited | INDSWFTLAB | Drug Manufacturers-Specialty & Generic | 138.17 | 8.16B | 5.13% | 1.92 | 1.78% |
| Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 230.42 | 7.54B | 3.82% | 15.72 | 416.89% |
| Themis Medicare Limited | THEMISMED | Drug Manufacturers-Specialty & Generic | 74.18 | 6.88B | 12.27% | 49.05 | 25.36% |
| TAKE Solutions Limited | TAKE | Biotechnology | 40.41 | 5.98B | 1.99% | n/a | -417.95% |
| Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 185.66 | 4.93B | 0.89% | 61.65 | 4.77% |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | Drug Manufacturers-Specialty & Generic | 77.43 | 4.59B | 6.40% | 20.75 | 2.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.75 | 24.85 | Cheaper |
| Ent. to Revenue | 2.05 | 11.40 | Cheaper |
| PE Ratio | 13.55 | 51.36 | Cheaper |
| Price to Book | 2.23 | 6.83 | Cheaper |
| Dividend Yield | 0.27 | 0.52 | Poor |
| Std. Deviation (3M) | 52.02 | 42.17 | Riskier |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 11.91B | 290.82B | Emerging |